Toxicity assessment and mechanistic investigation of engineered monoclinic VO2 nanoparticlesElectronic supplementary information (ESI) available. See DOI: 10.1039/c8nr02224k
Growing interest in monoclinic VO 2 nanoparticles (NPs) among consumers and the industries of window coatings, solar sensors etc . has brought particular attention to their safety concerns. The toxicity of this new class of nanomaterials in bacterial ecosystems has not yet been evaluated. The degree...
Saved in:
Main Authors | , , , , , , , , , , |
---|---|
Format | Journal Article |
Language | English |
Published |
24.05.2018
|
Online Access | Get full text |
Cover
Loading…
Summary: | Growing interest in monoclinic VO
2
nanoparticles (NPs) among consumers and the industries of window coatings, solar sensors
etc
. has brought particular attention to their safety concerns. The toxicity of this new class of nanomaterials in bacterial ecosystems has not yet been evaluated. The degree of crystallinity is a significant parameter that determines the performance of materials. However, the previously reported methods for toxicity assessment have neglected its influence. In this work, we systematically evaluated the toxicity of VO
2
NPs with different degrees of crystallinity to four typical bacterial strains and studied the influence of physicochemical properties and aging treatment on their antibacterial effect. The results showed that the toxicity of VO
2
nanoparticles was very low. Interestingly, we found that antibacterial properties of VO
2
NPs were dependent on both bacterial strains and VO
2
particle properties. In addition, the highly crystalline VO
2
NPs were more toxic than normal and industrial VO
2
particles. We attribute the crystallinity-related toxicity to the dissolved vanadium, the physical interactions between the bacteria and particles, and the generation of reactive oxygen species, as supported by our experimental results and theoretical calculation.
The toxicity and the influence of physicochemical properties and aging treatment of engineered monoclinic VO
2
nanoparticles were systematically evaluated. |
---|---|
Bibliography: | 10.1039/c8nr02224k Electronic supplementary information (ESI) available. See DOI |
ISSN: | 2040-3364 2040-3372 |
DOI: | 10.1039/c8nr02224k |